Correction to: Identification of ∆9-tetrahydrocannabinol (THC) impairment using functional brain imaging

Neuropsychopharmacology. 2022 May;47(6):1282. doi: 10.1038/s41386-022-01299-0.

Jodi M Gilman^{1

2

3}, William A Schmitt^{4

5}, Kevin Potter^{4

6}, Brian Kendzior, Gladys N Pachas^{4

6}, Sarah Hickey⁴, Meena Makary^{5

7}, Marilyn A Huestis⁸, A Eden Evins^{4

6}

¹ Massachusetts General Hospital (MGH) Department of Psychiatry, Boston, MA, USA. jgilman1@mgh.harvard.edu.
² Harvard Medical School, Boston, MA, USA. jgilman1@mgh.harvard.edu.
³ MGH/HST Athinoula A. Martinos Center for Biomedical Imaging, Department of Radiology, Massachusetts General Hospital, Harvard Medical School, Charlestown, MA, USA. jgilman1@mgh.harvard.edu.
⁴ Massachusetts General Hospital (MGH) Department of Psychiatry, Boston, MA, USA.
⁵ MGH/HST Athinoula A. Martinos Center for Biomedical Imaging, Department of Radiology, Massachusetts General Hospital, Harvard Medical School, Charlestown, MA, USA.
⁶ Harvard Medical School, Boston, MA, USA.
⁷ Faculty of Engineering, Cairo University, Cairo, Egypt.
⁸ Institute of Emerging Health Professions, Thomas Jefferson University, Philadelphia, PA, USA.

No abstract available

Publication types